购物车
- 全部删除
- 您的购物车当前为空
Ipragliflozin (ASP1941) 是一种口服有效的,选择性的 SGLT2抑制剂,对人 SGLT2 和 SGLT1,大鼠 SGLT2 和 SGLT1,小鼠 SGLT2 和 SGLT1 的 IC50分别为 7.38 和 1876 nM,6.73 和 1166 nM,5.64 和 1380 nM。Ipragliflozin 具有抗糖尿病活性。
Ipragliflozin (ASP1941) 是一种口服有效的,选择性的 SGLT2抑制剂,对人 SGLT2 和 SGLT1,大鼠 SGLT2 和 SGLT1,小鼠 SGLT2 和 SGLT1 的 IC50分别为 7.38 和 1876 nM,6.73 和 1166 nM,5.64 和 1380 nM。Ipragliflozin 具有抗糖尿病活性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 329 | 现货 | |
2 mg | ¥ 473 | 现货 | |
5 mg | ¥ 787 | 现货 | |
10 mg | ¥ 1,080 | 现货 | |
25 mg | ¥ 1,980 | 现货 | |
50 mg | ¥ 2,770 | 现货 | |
100 mg | ¥ 3,890 | 现货 | |
200 mg | ¥ 5,450 | 现货 | |
500 mg | ¥ 8,170 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 789 | 现货 |
产品描述 | Ipragliflozin (ASP1941) is under investigation in Type 2 Diabetes and Diabetes Mellitus, Type 2. |
靶点活性 | SGLT2:5.64 nM, SGLT2 (human):7.4 nM, SGLT2 (rat):6.73 nM |
激酶实验 | Inhibition of TNF-α synthesis: TNF-α inhibitory activity is measured in lipopolysacharide (LPS) stimulated PBMC. Pomalidomide is added to human PBMCs 1 hour prior to the addition of LPS (1 μg/mL) and incubation continued for an additional 18-20 hours. Supernatants are then harvested, and the concentration of TNF-α in the supernatants is determined by ELISA. The concentration of Pomalidomide that inhibits TNF- production by 50% (IC50) is calculated by nonlinear regression analysis. The human whole blood TNF- inhibition assay is run in a similar fashion to the PBMC assay except that heparinized fresh human whole blood is plated directly into microtiter plates. |
别名 | 伊格列净, ASP1941 |
分子量 | 404.45 |
分子式 | C21H21FO5S |
CAS No. | 761423-87-4 |
Smiles | O[C@H]1[C@@H](O[C@H](CO)[C@@H](O)[C@@H]1O)C2=CC(CC3=CC=4C(S3)=CC=CC4)=C(F)C=C2 |
密度 | 1.452 g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 70 mg/mL (173.07 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容